柳 晨,王俊杰,孟 娜,刘晓光,姜 亮,马永强,韩嵩博,袁慧书.CT引导下放射性125I粒子置入治疗脊柱转移性肿瘤的价值[J].中国脊柱脊髓杂志,2011,(3):226-229.
CT引导下放射性125I粒子置入治疗脊柱转移性肿瘤的价值
CT-guide interstitial iodine-125 seed implantation for metastatic spine tumor
投稿时间:2010-09-21  修订日期:2010-11-28
DOI:10.3969/j.issn.1004-406X.2011.3.226.3
中文关键词:  CT引导  125I粒子  脊柱肿瘤  转移  近距离治疗
英文关键词:CT-guide  Iodine-125 seed  Spinal tumor  Metastasis  Brachytherapy
基金项目:
作者单位
柳 晨 北京大学第三医院放射科 100191 北京市 
王俊杰 北京大学第三医院肿瘤治疗中心 100191 北京市 
孟 娜 北京大学第三医院肿瘤治疗中心 100192 北京市 
刘晓光  
姜 亮  
马永强  
韩嵩博  
袁慧书  
摘要点击次数: 4120
全文下载次数: 3083
中文摘要:
  【摘要】 目的:探讨CT引导下放射性125I粒子置入治疗脊柱转移性肿瘤的价值。方法:14例无法手术切除或放化疗的脊柱转移性肿瘤患者,均在CT引导下行放射性125I粒子置入术。置入术前应用三维治疗计划系统制定粒子置入计划。术中根据CT影像采取不同置入针排列方式种植粒子,粒子间距0.5~1.0cm。根据肿瘤大小及对放射线敏感程度置入粒子数范围26~145颗,粒子活度范围0.50~0.80mCi。术后即刻复查CT观察粒子分布情况,并再次应用三维治疗计划系统进行剂量验证。结果:14例患者均顺利完成手术。所有病例随访1~75个月,中位随访时间12.0个月。局部有效率50.0%,中位局部控制时间为26.0个月,1年、2年和3年局部控制率分别为62.5%、50.0%和37.5%。中位生存时间11.0个月,1年、2年和3年生存率分别为50.0%、41.7%和20.8%。神经功能保留率和恢复率分别为92.9%(13/14)和71.4%(10/14)。镇痛有效率和疼痛完全缓解率分别为78.6%(11/14)和64.3%(9/14)。结论:CT引导下放射性125I粒子置入治疗脊柱转移性肿瘤安全,并发症少,疗效确切,可作为不宜手术切除或放化疗患者的补充治疗方式。
英文摘要:
  【Abstract】 Objective:To investigate the value of CT-guide interstitial iodine-125 seed implantation for metastatic spine tumor.Method:14 patients with metastatic spine tumor,who did not have surgery,chemotherapy or external beam radiotherapy,underwent CT-guide interstitial iodine-125 seed implantation.Three-dimensional treatment system was used to determine the implantation plan.Different needles placement(0.5-1.0cm apart),number and distribution of seeds were determined according to the images,tumor sizes and sensitivity to radioactive rays. The mean number of seeds was 72(range,26-145),and the mean radioactive activity was 0.70mCi(range,0.50-0.80mCi).Three-dimensional treatment system was used for dose validation.Result:The mean follow-up was 12.0 months (range,1 to 75 months).The local control rate was 50.0%.The mean local control time and survival time was 26.0 months and 11.0 months repectively.The 1-year,2-year and 3-year local controls were 62.5%,50.0% and 37.5% respectively.The 1-year,2-year and 3-year survival rates were 50.0%,41.7% and 20.8% respectively.Preservation and recovery ratio of meurofunction were 92.9% and 71.4% respectively.Effect and complete pain relief ratio were 78.6% and 64.3% respectively.Conclusion:CT-guide interstitial iodine-125 seed implantation is minimally invasive and less-complication for spine metastatic tumor,which can be used as an alternative to convention surgery.
查看全文  查看/发表评论  下载PDF阅读器
关闭
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=6001EF4F3AE470745C3B8D6414AFD02A4A57917D9564DD45186B40019EFFB91FF3EC450B75278AF1F22F59EB61B1612174054BE86E3D82B3147C54C79C32278242994345E7800071A4B4B3F6AADB8372&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=527A01A248DACB72&jid=9262A66F274A6CFEEBE23EC40CDE54FC&yid=9377ED8094509821&aid=762DF5BC15256D81DCA53E972412A2F6&vid=&iid=38B194292C032A66&sid=6ED15D8DCB279BC4&eid=F8035C8B7D8A4264&fileno=20110312&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="527A01A248DACB72"; var my_jid="9262A66F274A6CFEEBE23EC40CDE54FC"; var my_yid="9377ED8094509821"; var my_aid="762DF5BC15256D81DCA53E972412A2F6";